FDA plans to put “black box” warning on Covid vaccines
Digest more
The decision applies to adolescents and adults and aligns with earlier US authorization for higher-risk groups.
CAMBRIDGE, MA / ACCESS Newswire / September 16, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced positive preliminary immunogenicity data for the 2025-2026 formula of Spikevax®, which targets ...
The U.S. is in "big danger" of falling behind in vaccine technology research as government funding declines and vaccine ...
Revenue -- $1.9 billion reported for the quarter, compared to prior sales cycles impacted by earlier U.S. COVID-19 vaccine ...
Researchers identified two immune signals that may help explain why a small percentage of young males develop chest pain or ...
French researchers say a massive real-world test of COVID shots turned up something vaccine skeptics won't like: People who ...
Health Secretary Robert F. Kennedy Jr. may have said he won't take vaccines away from anyone, but that's exactly what the ...
Opinion
5dOpinion
Undisclosed Deaths in the Pfizer mRNA COVID-19 Vaccine Trial Discussed in the Journal of American Physicians and Surgeons
The vaccines received Emergency Use Authorization (EUA) in December 2020 after only 20 weeks of testing, authors write. The highly atypical trial protocol was part of a “declared health emergency,” as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback